Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Translate Bio Inc (TBIO)

Translate Bio Inc (TBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction,...

TBIO : 14.78 (+0.20%)
Translate Bio to Participate in Upcoming Investor Conferences

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction,...

TBIO : 14.78 (+0.20%)
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress

-- Expanded collaboration with partner Sanofi Pasteur for all infectious diseases further unites Translate Bio's leading mRNA technology and large-scale manufacturing with Sanofi's world class vaccine...

TBIO : 14.78 (+0.20%)
What's in Store for Avenue Therapeutics (ATXI) in Q2 Earnings?

Avenue Therapeutics' (ATXI) sole pipeline candidate, tramadol, is under review. With lower clinical activities, operating expenses are likely to have declined during the second quarter.

TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
ACRX : 1.5700 (+14.60%)
ATXI : 11.50 (+3.05%)
What Awaits Selecta Biosciences (SELB) This Earnings Season?

In the absence of any marketed drugs, investor focus is likely to be on Selecta Biosciences' (SELB) lead pipeline candidate, SEL-212 on the second-quarter conference call.

TBIO : 14.78 (+0.20%)
SRPT : 144.53 (+0.35%)
ACRX : 1.5700 (+14.60%)
SELB : 2.60 (-1.52%)
Aldeyra (ALDX) to Report Q2 Earnings: What's in the Offing?

Aldeyra's (ALDX) pipeline progress will be in focus when it reports Q2 results later in the week.

BMY : 59.27 (-0.22%)
TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
ALDX : 7.43 (+4.50%)
CytoDyn (CYDY) to Report Q4 Earnings: What's in the Offing?

CytoDyn's progress on its lead candidate, leronlimab, will be in focus when it reports Q4 results.

INCY : 86.79 (-4.01%)
TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
CYDY : 3.5500 (+3.80%)
Actinium (ATNM) to Report Q2 Earnings: What's in the Cards?

Actinium's (ATNM) lead candidate, Iomab-B, being evaluated for acute myeloid leukemia will be in focus when the company reports second-quarter earnings.

TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
ACRX : 1.5700 (+14.60%)
ATNM : 10.33 (+7.94%)
Onconova (ONTX) to Report Q2 Earnings: What's in the Offing?

Investors will focus on pipeline updates when Onconova (ONTX) reports Q2 results.

INCY : 86.79 (-4.01%)
TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
ONTX : 0.3218 (+28.72%)
Is a Beat in the Cards for Bristol-Myers' (BMY) Q2 Earnings?

Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2020 results.

MRK : 85.81 (+0.20%)
INCY : 86.79 (-4.01%)
BMY : 59.27 (-0.22%)
TBIO : 14.78 (+0.20%)
Teva (TEVA) to Report Q2 Earnings: What's in the Cards?

On Teva's (TEVA) second-quarter conference call, investors will look for updates on the extent to which the coronavirus pandemic may have impacted sales of its products

TEVA : 9.48 (+2.05%)
TBIO : 14.78 (+0.20%)
PCRX : 60.77 (+1.47%)
ACRX : 1.5700 (+14.60%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Translate Bio, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Translate Bio, Inc. ("Translate" or "the Company") (NASDAQ: TBIO)...

TBIO : 14.78 (+0.20%)
Translate Bio (TBIO) in Focus: Stock Moves 11.7% Higher

Translate Bio (TBIO) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.

TBIO : 14.78 (+0.20%)
SLNO : 1.9400 (-2.51%)
Translate Bio Announces Pricing of Public Offering of Common Stock

Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene...

TKPYY : 16.5900 (-0.90%)
TBIO : 14.78 (+0.20%)
Translate Bio Announces Proposed Public Offering of Common Stock

Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene...

TKPYY : 16.5900 (-0.90%)
TBIO : 14.78 (+0.20%)
Translate Bio Up on Vaccine Agreement Expansion With Sanofi

Translate Bio (TBIO) and Sanofi expand their tie-up to develop mRNA vaccines for infectious diseases. The deal boosts the company's cash resources significantly along with potential future revenues.

SNY : 52.44 (+0.71%)
TBIO : 14.78 (+0.20%)
BLCM : 7.74 (+12.17%)
ALPN : 8.67 (+4.08%)
Company News for Jun 24, 2020

Companies In The News Are: SPR, BA, EA, TBIO, SNY, MYOV.

BA : 161.14 (-3.81%)
SNY : 52.44 (+0.71%)
SPR : 20.95 (+0.92%)
TBIO : 14.78 (+0.20%)
EA : 125.90 (+0.51%)
MYOV : 21.99 (+4.12%)
Sanofi Expands Agreement With Translate Bio for mRNA Vaccines

Sanofi (SNY) and Translate Bio expand their tie-up to develop mRNA vaccines for infectious diseases. The companies are already developing a mRNA vaccine candidate to combat COVID-19.

REGN : 555.24 (-1.73%)
SNY : 52.44 (+0.71%)
GSK : 39.26 (-0.53%)
TBIO : 14.78 (+0.20%)
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas

-- The two companies will build upon their existing collaboration to pursue novel mRNA vaccines aimed at broadly addressing current and future infectious diseases --

TBIO : 14.78 (+0.20%)
Sanofi (SNY) to Create Dedicated Vaccine Center in France

Sanofi (SNY) plans to invest almost $690 billion to develop a new production site and research center in France with both dedicated to vaccines.

REGN : 555.24 (-1.73%)
SNY : 52.44 (+0.71%)
GSK : 39.26 (-0.53%)
TBIO : 14.78 (+0.20%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar